Starry's subsidiary has obtained the drug registration certificate for Iopamidol Injection
I'm PortAI, I can summarize articles.
Starry's wholly-owned subsidiary, Shanghai Starry Pharmaceutical Co., Ltd., recently obtained the drug registration certificate for Iopromide Injection issued by the National Medical Products Administration. This drug is used for various diagnostic purposes, including CT enhancement, arterial and venous angiography, and is particularly suitable for cardiovascular angiography and other cavity examinations, but is not suitable for intrathecal use
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments